Table 1:
Characteristics of All Patients Tested for SARS-CoV-2 by Health Care Worker (HCW) Status
| Non-HCW Number(%) or MediantInterquaitile Range] |
HCW Number(%) or Mediantlnterquartile Range] |
p-value | |
|---|---|---|---|
| Number | 66764 | 6145 | |
| SARS-CoV-2 Positive | 4353 ( 6.5) | 551 ( 9.0) | <0.001 |
| Demographics: | |||
| Location | <0.001 | ||
| Ohio | 50204 ( 75.2) | 5642 ( 91.8) | |
| Florida | 13957 ( 20.9) | 503 ( 8.2) | |
| Unknown | 2603 ( 3.9) | 0 | |
| Race | <0.001 | ||
| Asian | 672 ( 1.0) | 206 ( 3.4) | |
| Black | 12201 ( 18.3) | 995 ( 16.2) | |
| Other | 5394 ( 8.1) | 490 ( 8.0) | |
| White | 48497 ( 72.6) | 4454 ( 72.5) | |
| Male | 29959 ( 44.9) | 1322 ( 21.5) | <0.001 |
| Non-Hispanic | 58496 ( 87.6) | 5577 ( 90.8) | <0.001 |
| Smoking | <0.001 | ||
| Current Smoker | 9316 ( 14.0) | 147 ( 2.4) | |
| Former Smoker | 30196 ( 45.2) | 1737 ( 28.3) | |
| No | 27048 ( 40.5) | 4259 ( 69.3) | |
| Unknown | 204 ( 0.3) | 2 ( 0.0) | |
| Age | 57.53 [39.32, 70.26] | 39.67 [31.29, 51.80] | <0.001 |
| Exposure history: | |||
| Exposed to COVID-19 | 11369 ( 17.0) | 4424 ( 72.0) | <0.001 |
| Family member with COVID-19 | 9503 ( 14.2) | 1740 (28.3) | <0.001 |
| Presenting symptoms: | |||
| Cough | 19744 ( 29.6) | 1968 ( 32.0) | 0.001 |
| Fever | 12997 ( 19.5) | 922 ( 15.0) | <0.001 |
| Fatigue | 8020 ( 12.0) | 637 ( 10.4) | <0.001 |
| Sputum production | 402 ( 0.6) | 45 ( 0.7) | 0.244 |
| Flu-like symptoms | 5949 ( 8.9) | 423 ( 6.9) | <0.001 |
| Shortness of breath | 17133 ( 25.7) | 898 ( 14.6) | <0.001 |
| Diarrhea | 6335 ( 9.5) | 731 ( 11.9) | <0.001 |
| Loss of appetite | 1505 ( 2.3) | 299 ( 4.9) | <0.001 |
| Vomiting | 6471 ( 9.7) | 454 ( 7.4) | <0.001 |
| Co-morbidities: | |||
| Body Mass Index | 28.37 [25.85, 31.07] | 28.37 [27.37, 29.13] | <0.001 |
| Chronic Obstructive Pulmonary Disease/emphysema | 8247 ( 12.4) | 166 ( 2.7) | <0.001 |
| Asthma | 12057 ( 18.1) | 1343 ( 21.9) | <0.001 |
| Diabetes | 13418 ( 20.1) | 428 ( 7.0) | <0.001 |
| Hypertension | 30727 ( 46.0) | 1505 ( 24.5) | <0.001 |
| Coronary artery disease | 10181 ( 15.2) | 204 ( 3.3) | <0.001 |
| Heart failure | 8192 ( 12.3) | 93 ( 1.5) | <0.001 |
| Cancer | 12469 ( 18.7) | 646 ( 10.5) | <0.001 |
| Transplant history | 1120 ( 1.7) | 19 ( 0.3) | <0.001 |
| Multiple sclerosis | 493 ( 0.7) | 43 ( 0.7) | 0.794 |
| Connective tissue disease | 2376 ( 3.6) | 178 ( 2.9) | 0.008 |
| Inflammatory Bowel Disease | 1604 ( 2.4) | 112 ( 1.8) | 0.005 |
| Immunosuppressive disease | 10375 ( 15.5) | 414 ( 6.7) | <0.001 |
| Vaccination history: | |||
| Influenza vaccine | 30340 ( 45.4) | 5277 ( 85.9) | <0.001 |
| Pneumococcal polysaccharide vaccine | 17808 ( 26.7) | 451 ( 7.3) | <0.001 |
| Laboratory findings upon presentation: | |||
| Pre-testing platelets | 238.00 [238.00, 238.00] | 238.00 [238.00, 238.00] | 0.137 |
| Pre- testing AST | 23.00 [23.00, 23.00] | 23.00 [23.00, 23.00] | 0.051 |
| Pre- testing BUN | 16.00 [16.00, 16.00] | 16.00 [16.00, 16.00] | <0.001 |
| Pre- testing Chloride | 101.00 [101.00, 101.00] | 101.00 [101.00, 101.00] | 0.092 |
| Pre- testing Creatinine | 0.92 [0.92, 0.92] | 0.92 [0.92, 0.92] | <0.001 |
| Pre-testing hematocrit | 39.50 [39.50, 39.50] | 39.50 [39.50, 39.50] | 0.41 |
| Pre- testing Potassium | 4.10 [4.10, 4.10] | 4.10 [4.10, 4.10] | 0.081 |
| Home medications: | |||
| Immunosuppressive treatment | 2392 (3.6) | 270 ( 4.4) | <0.001 |
| Nonsteroidal Anti-inflammatory Drugs | 19651 ( 29.4) | 1048 ( 17.1) | <0.001 |
| Steroids | 11838 ( 17.7) | 969 ( 15.8) | <0.001 |
| Carvedilol | 2803 ( 4.2) | 40 ( 0.7) | <0.001 |
| Angiotensin converting enzyme inhibitor | 7568 ( 11.3) | 329 ( 5.4) | <0.001 |
| Angiotensin receptor blocker | 5698 ( 8.5) | 228 ( 3.7) | <0.001 |
| Melatonin | 3078 ( 4.6) | 52 ( 0.8) | <0.001 |
| Social influencers of health: | |||
| Population Per Square Kilometer | 3.03 [2.63, 3.29] | 3.01 [2.64, 3.28] | 0.568 |
| Median Income per $1000 | 58.09 [41.62, 76.21] | 64.78 [49.78, 85.54] | <0.001 |
| Population Per Housing Unit | 2.22 [1.93, 2.49] | 2.26 [2.01, 2.51] | <0.001 |